We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Dings Drugmaker for Lax Reviews into Quality Problems
FDA Dings Drugmaker for Lax Reviews into Quality Problems
Novel Laboratories failed to adequately address black specks on drug products and pieces of rubber found in a product container, according to a Form 483 given to the drugmaker.